BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33742034)

  • 41. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow.
    Garderet L; Labopin M; Gorin NC; Polge E; Fouillard L; Ehninger GE; Ringden O; Finke J; Tura S; Frassoni F
    Bone Marrow Transplant; 2003 Jan; 31(1):23-9. PubMed ID: 12621503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
    Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
    Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
    Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
    Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [CEBPA gene mutation analysis in acute myeloid leukemia].
    Han C; Lin D; Ai XF; Wang F; Sun HY; Wang M; Mi YC; Wang JX; Ru K
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):566-71. PubMed ID: 23906447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular evaluation of CEBPA gene mutation in normal karyotype acute myeloid leukemia: a comparison of two methods and report of novel CEBPA mutations from Indian acute myeloid leukemia patients.
    Ahmad F; Rajput S; Mandava S; Das BR
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):707-15. PubMed ID: 22731647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic Leukapheresis in Pediatric Leukemia: Utilization Trend and Early Outcomes in a US Nationwide Cohort.
    Takahashi T; Turcotte LM; Gordon PM; Johnson AD; Rubin N; Spector LG
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):47-53. PubMed ID: 33735152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia.
    Schmitt A; Reinhardt P; Hus I; Tabarkiewicz J; Roliñski J; Barth T; Giannopoulos K; Dmoszyñska A; Wiesneth M; Schmitt M
    Transfusion; 2007 Sep; 47(9):1588-94. PubMed ID: 17725721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage.
    Chang MC; Chen TY; Tang JL; Lan YJ; Chao TY; Chiu CF; Ho HT
    Am J Hematol; 2007 Nov; 82(11):976-80. PubMed ID: 17636473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].
    Miyazaki T; Abe N; Yamazaki E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Tachibana T; Kamijo A; Tomita N; Ishigastubo Y
    Rinsho Ketsueki; 2016 Feb; 57(2):180-5. PubMed ID: 26935637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation.
    Wang H; Li XQ; Chu TT; Han SY; Qi JQ; Tang YQ; Qiu HY; Fu CC; Tang XW; Ruan CG; Wu DP; Han Y
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2659-2670. PubMed ID: 33550446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis.
    Fos J; Pabst T; Petkovic V; Ratschiller D; Mueller BU
    Blood; 2011 May; 117(18):4881-4. PubMed ID: 21389317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reclassification of Acute Myeloid Leukemia According to the 2016 WHO Classification.
    Jung J; Cho BS; Kim HJ; Han E; Jang W; Han K; Lee JW; Chung NG; Cho B; Kim M; Kim Y
    Ann Lab Med; 2019 May; 39(3):311-316. PubMed ID: 30623623
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.
    Xu Y; Sun Y; Shen H; Ding L; Yang Z; Qiu H; Sun A; Chen S; Wu D
    Am J Hematol; 2015 Nov; 90(11):992-7. PubMed ID: 26223865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
    Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group.
    Kinoshita A; Miyachi H; Matsushita H; Yabe M; Taki T; Watanabe T; Saito AM; Tomizawa D; Taga T; Takahashi H; Matsuo H; Kodama K; Ohki K; Hayashi Y; Tawa A; Horibe K; Adachi S
    Br J Haematol; 2014 Oct; 167(1):80-6. PubMed ID: 25039450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis.
    Awad MM; Aladle DA; Abousamra NK; Elghannam DM; Fawzy IM
    Hematology; 2013 Mar; 18(2):61-8. PubMed ID: 22990006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness and safety of leukapheresis in hyperleukocytic leukemias: a retrospective multicenter study.
    Zhang X; Tu Y; Shen J; Feng Y; Ma H; Bai L; Li X; Lin Z; Dai L; Gong F; Lu T; Zhou J; Chen H; Lv Q; Zhu Z; Ruan C
    Leuk Lymphoma; 2022 Nov; 63(11):2636-2644. PubMed ID: 35731036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis.
    Creutzig U; Rössig C; Dworzak M; Stary J; von Stackelberg A; Wössmann W; Zimmermann M; Reinhardt D
    Pediatr Blood Cancer; 2016 Apr; 63(4):640-5. PubMed ID: 26670831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients.
    Jabo B; Morgan JW; Martinez ME; Ghamsary M; Wieduwilt MJ
    PLoS One; 2017; 12(4):e0174760. PubMed ID: 28384176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are outcomes for childhood leukaemia in Australia influenced by geographical remoteness and Indigenous race?
    Jessop S; Ruhayel S; Sutton R; Youlden DR; Pearson G; Lu C; Milne S; Henderson MJ; Aitken JF; Kotecha RS; Revesz T
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28945. PubMed ID: 33565233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.